-+ 0.00%
-+ 0.00%
-+ 0.00%

COGNITION THERAPEUTICS ANNOUNCES ISSUANCE OF COMPOSITION OF MATTER PATENT, EXTENDING PROTECTION FOR ZERVIMESINE (CT1812) THROUGH 2045

Reuters·10/13/2026 10:02:01